Clinical Trials Logo

Implant Tissue Failure clinical trials

View clinical trials related to Implant Tissue Failure.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04679922 Completed - Clinical trials for Implant Tissue Failure

Fascia Lata Allograft Versus Subepithelial Connective Tissue Grafts in the Peri-Implant Mucosal Thickness Enhancement.

Fascia Lata
Start date: December 10, 2019
Phase: N/A
Study type: Interventional

The aim of this, randomized clinical trial is to determine the clinical efficacy of fascia lata allograft in terms of peri-implant mucosal augmentation, as compared to autologous sub epithelial connective tissue graft, clinically and histologically in human adults .

NCT ID: NCT04160689 Completed - Bone Loss Clinical Trials

Influence of the Implant Connection on Facial Tissues Maturation

Start date: November 1, 2018
Phase: Phase 4
Study type: Interventional

The substitution of a tooth with a fixture often induces undesired morphological changes, resulting in a deterioration of the aesthetic appearance. The purpose of this study is to compare the soft tissue behavior next to two different implant connections: 5° (group 1) and 35° hexed (group 2), conical, internal with switching platform design after 12 months of functional provisionalization

NCT ID: NCT04139512 Completed - Clinical trials for Implant Tissue Failure

One-abutment One-time for Immediate Restoration Procedure in the Esthetic Zone

IONE
Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

Objectives: The aim of this randomized control trial was to compare immediate restoration procedure with a one abutment one-time technique using a conventional versus full digital workflow. Surgical accuracy, provisional fit and patient reported outcome measures (PROMs) of.

NCT ID: NCT04054271 Completed - Clinical trials for Implant Tissue Failure

Effects of ABO Blood Types on the Survival and Marginal Bone Resorption of Dental Implants

Start date: December 15, 2017
Phase:
Study type: Observational

This study evaluates implant survival and marginal bone resorption in patients receiving implant treatment with respect to demographic data and AB0 (groups) blood types.